InBody Overview
- Year Founded
-
1996
- Status
-
Public
- Employees
-
318
- Stock Symbol
-
041830
- Investments
-
1
- Share Price
-
$18.64
- (As of Friday Closing)
InBody General Information
Description
InBody Co Ltd is a Korea-based company engaged in the manufacturing and distribution of body composition analyzers. The company mainly produces body composition analyzers under the brand name InBody and Lookin'Body. It's InBody series products include InBody720, InBody570, InBody230, InBody J30, and InBody S10.
Contact Information
- InBogy Building, 54, Nonhyeon-ro 2-gil
- Gangnam-gu
- Seoul, 135-960
- South Korea
InBody Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $18.64 | $18.52 | $13.85 - $24.73 | $243M | 13M | 27.7K | $2.06 |
InBody Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | 173,015 | 154,208 | 196,669 | 158,983 |
| Revenue | 130,234 | 123,831 | 120,337 | 90,728 |
| EBITDA | 35,801 | 35,993 | 37,708 | 20,980 |
| Net Income | 26,860 | 26,171 | 29,713 | 14,837 |
| Total Assets | 201,295 | 192,148 | 171,224 | 152,303 |
| Total Debt | 5,201 | 5,065 | 3,250 | 4,395 |
InBody Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
InBody Comparisons
Industry
Financing
Details
00000
InBody Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 00000 | Venture Capital-Backed | Los Angeles, CA | 00 | 00000 | 00000 00000 | 00000 |
InBody Patents
InBody Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220076820-A1 | Methods and apparatus for biometric data | Pending | 10-Sep-2020 | 000000000 | 0 |
| US-20230218191-A1 | Body composition measuring device using nine segments and operation method thereof | Pending | 08-Jul-2020 | 0000000000 | |
| US-11583230-B2 | Electrode patch | Active | 07-Jun-2019 | 00000000 | 00 |
| US-20200383640-A1 | Electrode patch | Active | 07-Jun-2019 | 000000000 | 0 |
| US-D932026-S1 | Electrode for body water measurer | Active | 02-Apr-2019 | 0 |
InBody Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Kichul Cha MD | Founder & Chief Executive Officer |
InBody Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000-000 0000000 | InBody | Board Member | 000 0000 |
InBody Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
InBody Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
InBody Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Common Computer | 28-Jul-2023 | 00000 0000 | 00.00 | Systems and Information Management | 000000 00 |
InBody ESG
Risk Overview
Risk Rating
Updated April, 21, 2023
34.52 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.0
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,708
Rank
Percentile
Healthcare
Industry
00 of 626
Rank
Percentile
Medical Devices
Subindustry
00 of 213
Rank
Percentile
